ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Treatment Doesn’t Always Follow Recommendations

February 25, 2005

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998

UICC Grant Programs Available To Support International Activities

April 16, 1976

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000

Adverse Events Of Chemo More Common Than Expected

August 25, 2006